CDH1 and in situ carcinoma: Epithelial markers (KRT18, KRT7, CDH1, and EPCAM) were alleviated in SKOV3 CIS, compared to wild-type SKOV3, while mesenchymal markers (VIM) were highly expressed, except CDH2, which decreased after CIS exposure (Figure 6B).